288.
Shear stress and the endothelium / B. J. Ballermann [et al.] // Kidney Int.
Suppl. – 1998. – Vol. 67. – P. 100-108.
289.
Shupp M. Telmisartan: from Lowering blood pressure to end-organ protection
/ M. Shupp, T. Under // Future Cardiol. – 2005. – Vol. № 1. – P.7-15.
290.
Sibutramine produces dose-related weight loss / G. A. Bray [et al.] // Obes.
Res. – 1999. – Vol. 7, № 2. – P. 189-198.
291.
s-ICAM-1 and s-VCAM-1 in healthy men are strongly associated with traits of
the metabolic syndrome, becoming evident in the postprandial response to a lipid-
rich meal / D. Rubin [et al.] // Lipids Health. Dis. – 2008. – № 7. – P. 32.
292.
Soluble leptin receptor in serum of subjects with complete resistance to leptin:
relation to fat mass / N. Lahlou [et al.] // Diabetes. – 2000. – Vol. 49. – P. 1347-
1352.
293.
Sowers J. R. Obesity as a cardiovascular risk factor / J. R. Sowers // Am. J.
Med. – 2003. – Vol. 115. – Р. 37-41.
294.
Spatial comparison between wall shear stress measures and porcine arterial
endothelial permeability / H. A. Himburg [et al.] // Am. J. Physiol. Heart Circ.
Physiol. – 2004. – Vol. 286, № 5. – P. 1916-1922.
295.
Stamler J.
/ J. Stamler, J. D. Neaton // JAMA. – 2008. – Vol. 300, № 11. – P.
1343-1345.
296.
Stimulation of endotelin mRNA and secretion in rat vascular smooth muscle
cells: a novel autocrine function / T. J. Resink [et al.] // Cell Regul. – 1990. – Vol.
1, № 9. – P. 649-659.
297.
Summary of the 2007 European Society of Hypertension (ESH) and European
Society of Cardiology (ESC) guidelines for the management of arterial
hypertension // Vasc. Health Risk Manag. – 2007. – Vol. 3, № 6. – P. 783-795.
298.
Sympathetic activation in cardiovascular and renal disease / G. Grassi [et al.] //
J. Nephrol. – 2009. – Vol. 22, № 2. – P. 190-195.
